Japanese Health Ministry To Ask Drug Makers To Submit Applications For 100-plus Pharmaceutical Products; Vows Quick Review Process
This article was originally published in PharmAsia News
Executive Summary
TOKYO - In an unusual move aimed at solving part of Japan's drug lag problem, the Ministry of Health, Labor and Welfare is set to ask pharmaceutical makers to submit applications to market a total of 109 drugs that have already been approved in other countries, an MHLW official said May 10
You may also be interested in...
Japan Urges Development Of 91 Drugs; Seeks Public Recruitment For 17 To Ease Drug Lag
TOKYO - The Ministry of Health, Labor and Welfare has asked pharmaceutical manufacturers that have licenses to proactively develop 91 products in Japan that are not currently approved for use in Japan, ministry officials said June 2. Of the total, the ministry began publicly recruiting developers for 19 drugs
Japan Urges Development Of 91 Drugs; Seeks Public Recruitment For 17 To Ease Drug Lag
TOKYO - The Ministry of Health, Labor and Welfare has asked pharmaceutical manufacturers that have licenses to proactively develop 91 products in Japan that are not currently approved for use in Japan, ministry officials said June 2. Of the total, the ministry began publicly recruiting developers for 19 drugs
Regulators In Japan Cut Away At New Drug Review Time
TOKYO - Japan is posting an overall improvement in shortening the average time it takes regulators to review new drugs, according to a government evaluation committee that rated the operational performance of the Pharmaceuticals and Medical Devices Agency